TY  - GEN
AU  - Himelstein,Andrew L
AU  - Foster,Jared C
AU  - Khatcheressian,James L
AU  - Roberts,John D
AU  - Seisler,Drew K
AU  - Novotny,Paul J
AU  - Qin,Rui
AU  - Go,Ronald S
AU  - Grubbs,Stephen S
AU  - O'Connor,Tracey
AU  - Velasco,Mario R
AU  - Weckstein,Douglas
AU  - O'Mara,Ann
AU  - Loprinzi,Charles L
AU  - Shapiro,Charles L
TI  - Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial
SN  - 1538-3598
PY  - 2017///0209
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Bone Neoplasms
KW  - secondary
KW  - Bone and Bones
KW  - radiation effects
KW  - Breast Neoplasms
KW  - pathology
KW  - Diphosphonates
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Pain Measurement
KW  - Prostatic Neoplasms
KW  - Sample Size
KW  - Spinal Cord Compression
KW  - surgery
KW  - Spinal Fractures
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1001/jama.2016.19425
ER  -